Xilio Therapeutics, Inc. Common Stock (XLO)

$7.95 +2.71%
EARNINGS ANALYTICS
event_upcoming Next Earnings: 2026-08-11 HIGH CONFIDENCE
search

Xilio Therapeutics, Inc. Common Stock (XLO) has a 18-report earnings history dating back to Dec 02, 2021. Its average absolute post-earnings move is ±10.38%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +81.9% (Mar 28, 2024) and its largest decline was -21.88% (Aug 09, 2022). The next earnings report is predicted for 2026-08-11 (high confidence).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

18

Avg Abs. Movement

±10.38%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
Mar 23, 2026 ☀ PRE $8.04 $8.04 $8.01 434 +2.56% open_in_new
Nov 13, 2025 ☀ PRE $0.72 $0.72 $0.70 52,154 -8.47% open_in_new
Aug 14, 2025 ☀ PRE $0.69 $0.70 $0.70 5,300 -2.21% open_in_new
May 08, 2025 ☀ PRE $0.73 $0.73 $0.73 1,715 +10.14% open_in_new
Mar 11, 2025 ☀ PRE $0.76 $0.79 $0.79 7,985 -9.4% open_in_new
Nov 07, 2024 ☀ PRE $1.24 $1.24 $1.03 22,513 -20.38% open_in_new
Aug 08, 2024 ☀ PRE $0.88 $0.88 $0.88 0 +0% open_in_new
May 14, 2024 ☀ PRE $1.09 $1.10 $1.10 677 +2.31% open_in_new
Mar 28, 2024 ☀ PRE $1.93 $1.93 $1.07 391,637 +81.9% open_in_new
Nov 09, 2023 ☽ POST $1.74 $1.74 $1.57 902 -4.14% open_in_new
Aug 14, 2023 ☀ PRE $2.63 $2.63 $2.63 0 +0% open_in_new
May 09, 2023 ☀ PRE $2.55 $2.55 $2.55 0 +0% open_in_new
Mar 02, 2023 ☽ POST $3.22 $3.25 $2.97 921 +3.54% open_in_new
Nov 09, 2022 ☀ PRE $2.34 $2.34 $2.34 0 +0% open_in_new
Aug 09, 2022 ☀ PRE $2.46 $2.86 $2.50 1,587 -21.88% open_in_new
May 12, 2022 ☀ PRE $3.14 $3.26 $2.97 2,114 -1.66% open_in_new
Mar 01, 2022 ☀ PRE $11.92 $11.97 $10.94 693 -6.5% open_in_new
Dec 02, 2021 ☀ PRE $16.41 $16.45 $14.10 6,199 -11.82% open_in_new
event

Earnings Count

18

Total earnings in dataset

trending_up

Avg Abs. Movement

±10.38%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

6 most recent
Form Date Filed View on EDGAR
EFFECT 20260529 open_in_new SEC.gov
S-3/A 20260527 open_in_new SEC.gov
SCHEDULE 13G/A 20260515 open_in_new SEC.gov
SCHEDULE 13G/A 20260515 open_in_new SEC.gov
SCHEDULE 13G 20260515 open_in_new SEC.gov
SCHEDULE 13G 20260515 open_in_new SEC.gov

Frequently asked about XLO earnings

When does Xilio Therapeutics, Inc. Common Stock report earnings next? expand_more

Xilio Therapeutics, Inc. Common Stock (XLO)'s next earnings date is predicted (high confidence) for 2026-08-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does XLO stock move after earnings? expand_more

Over 18 reports, XLO has moved an average of ±10.38% the session after earnings, closing higher 50.0% of the time.

What was XLO's biggest post-earnings move? expand_more

XLO's largest post-earnings gain on record was +81.9% on Mar 28, 2024, and its largest decline was -21.88% on Aug 09, 2022.

Where can I find Xilio Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Xilio Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers